Friday, May 8, 2009

Teva Announces Extension of Patent Protection for Azilect

May 6, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the USPTO has awarded a five year patent term extension to one of Teva's Orange Book patent (U.S. 5,453,446) covering Azilect (Rasagiline).

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)